Dharmacon was founded in 1995 by Stephen Scaringe as Dharmacon Research to develop and commercialize a new technology for RNA oligonucleotide synthesis. The original Dharmacon focus and vision was to develop 2'-ACE RNA technology as the standard for RNA synthesis and to advance RNA oligo-dependent applications and technologies. When RNA interference (RNAi) emerged in the late 1990s, Dharmacon was poised to provide RNAi-related products to the multitude of academic and industry researchers.
| Attributes | Values |
|---|---|
| rdfs:comment |
|
| foaf:name |
|
| founding year |
|
| industry | |
| key person | |
| location | |
| number of employees |
|
| product | |
| type |